Overview

HOKUYAKU TAKEYAMA Holdings,Inc.

Hokuyaku-Takeyama Holdings is a comprehensive healthcare group headquartered in Sapporo, operating primarily in Hokkaido across five business segments: pharmaceutical wholesale, medical device wholesale, dispensing pharmacy, nursing care, and ICT solutions for healthcare institutions. Its pharmaceutical wholesale subsidiary, Hokuyaku, is the No.1 pharmaceutical wholesaler in Hokkaido, leveraging a logistics network of over 20 branches across the island. The group also operates over 60 dispensing pharmacies in Hokkaido and provides medical ICT software development, in-hospital logistics (SPD), and care facility management services.

Market Cap
¥—B
EV
¥—B
US$1 = ¥156.80 (2026-10-23)
LTM EV/EBITDA
—
LTM EV/EBIT
—
LTM PER
—
LTM PBR
—
No price data
Stock data unavailable
This company is listed on a regional exchange (Nagoya/Fukuoka/Sapporo) and is not distributed via J-Quants (JPX). Stock price, market cap, and EV-based multiples are not available. Financial data from public filings (P&L, BS, directors, etc.) remains accurate for analysis.
AI Briefing
Generating insights…
Performance & Balance
Revenue 5Y (¥B)
248US$1.58B'22/3262US$1.67B'23/3275US$1.76B'24/3290US$1.85B'25/3304US$1.94B'26/3
EBITDA 5Y (¥B)
3.21US$20.5M'22/33.71US$23.7M'23/33.89US$24.8M'24/34.07US$26.0M'25/32.99US$19.0M'26/3
Net Income 5Y (¥B)
2.80US$17.9M'22/32.73US$17.4M'23/32.18US$13.9M'24/32.47US$15.8M'25/31.68US$10.7M'26/3
Capital Structure
99%
EquityD/E 0.01xDebt
Liquidity vs Debt 5Y (¥B)▲ Net Cash
CashInv. Sec.Debt
36.6US$233M0.02US$0.11M'22/333.4US$213M0.02US$0.10M'23/338.5US$246M0.01US$0.09M'24/334.8US$222M0.31US$1.98M'25/336.5US$233M0.45US$2.85M'26/3
Shareholders
Top 10 hold 46.6%
1
Itsuwa Planning Co., Ltd.
13.03%
2
Task Planning Co., Ltd.
6.85%
3
Astem Co., Ltd.
6.31%
4
The Hokkaido Bank, Ltd.
4.36%
5
North Pacific Bank,Ltd.
3.93%
6
Employee Stock Ownership Association
2.82%
7
Eisai Co.,Ltd.
2.66%
8
Sumitomo Pharma Co.,Ltd.
2.28%
9
Vitalnet Co., Ltd.
2.23%
10
DAIICHI SANKYO COMPANY,LIMITED
2.13%
Management
15 officers
Masaaki MANABE
Representative Director, Chairman
Apr 1965 Joined Manabe Goro Pharmacy Co., Ltd. (now Hokuyaku Co., Ltd.) Apr 1991 Representative Director, President, Valeo Co., Ltd. (now Hokuyaku Co., Ltd.) Jun 2003 Representative Director, President and Executive Officer, Valeo Co., Ltd. Sep 2006 Representative Director, President, the Company Jun 2007 Representative Director, President and Executive Officer, the Company Jun 2009 Director, Chairman, Takeyama Co., Ltd. Jun 2012 Representative Director, Chairman, Hokuyaku Co., Ltd. (current) Jun 2015 Representative Director, President, the Company Jun 2018 Representative Director, Chairman, the Company (current)
1942-11-27
Masanobu MANABE
Representative Director, President
Aug 1989 Joined Manabe Pharmaceutical Co., Ltd. (now Hokuyaku Co., Ltd.) Jun 2003 Director and Executive Officer, Manabe Pharmaceutical Co., Ltd. Oct 2004 Managing Executive Officer and General Manager, Pharmaceutical Sales Division, Manabe Pharmaceutical Co., Ltd. Jun 2005 Director and Senior Managing Executive Officer, General Manager, Pharmaceutical Sales Division, Manabe Pharmaceutical Co., Ltd. Sep 2006 Director, General Manager of Sales, the Company Jun 2007 Representative Director and Senior Managing Executive Officer, General Manager, Pharmaceutical Sales Division, Hokuyaku Co., Ltd. Sep 2007 Director and Senior Managing Executive Officer, in charge of Pharmaceutical Business and General Manager of Sales, the Company Jun 2009 Representative Director and Executive Vice President, Hokuyaku Co., Ltd. Jun 2009 Representative Director and Senior Managing Executive Officer, in charge of Business Strategy, the Company Jun 2012 Representative Director, President and Executive Officer, Hokuyaku Co., Ltd. Jul 2012 Representative Director and Senior Managing Executive Officer, in charge of Pharmaceutical Business, the Company Jun 2014 Representative Director and Executive Vice President, in charge of Pharmaceutical Business, the Company Jun 2015 Representative Director, President, Hokuyaku Co., Ltd. (current) Jun 2015 Representative Director and Executive Vice President, in charge of Pharmaceutical Business, the Company Jun 2018 Representative Director, President, the Company (current) Jun 2022 Director, Chairman, Takeyama Co., Ltd. (current)
1966-12-21
Shigeki TAKEYAMA
Director
Mar 1991 Joined Takeyama Co., Ltd. Mar 1995 Director, Takeyama Co., Ltd. Jun 2006 Director and Executive Vice President, Takeyama Co., Ltd. Sep 2006 Director, General Manager of Business Strategy Department, the Company Jun 2007 Director and Executive Officer, Head of Business Planning Office, Management Division, the Company Jun 2008 Representative Director, Takeyama Co., Ltd. (current) Jul 2008 Director and Executive Officer, General Manager, Management Division, the Company Jul 2012 Director and Executive Officer, Head of SPD Business Division, the Company Jun 2015 Director and Executive Officer, General Manager, President's Office, Business Planning Department, the Company Jun 2016 Director and Managing Executive Officer, in charge of ICT Business, the Company; Representative Director, President, Adwick Co., Ltd. Jun 2018 Managing Executive Officer, in charge of ICT Business, the Company Jun 2021 Director, the Company Jun 2023 Director, in charge of ICT Business, the Company Jun 2024 Director, Chairman, Adwick Co., Ltd. (current) Jul 2024 Director, in charge of ICT Business, General Manager of Legal Division and General Manager of Legal Department, the Company (current)
1965-10-16
Takamasa KOBAYASHI
Director
Apr 1984 Joined Orient Lease Co., Ltd. Jul 1987 Assistant Manager, Bond Division, Tokyo Branch, Citicorp Vickers Securities May 1989 Chief Researcher, Financial Strategy Department, Tokyo Branch, Goldman Sachs Securities Jan 1992 Representative Director, President, Nihon A.L.M. K.K. May 1993 Representative Director, President, Hokuto Lease Co., Ltd. Jun 2001 Representative Director, President, Nihon A.L.M. K.K. Oct 2012 Joined the Company Jan 2013 Managing Officer, Business Planning Department, the Company May 2013 Representative Director, President, Morus Co., Ltd. (current) Jun 2015 Executive Officer, General Manager of Business Planning Department, the Company Jul 2019 Managing Executive Officer, in charge of Business Strategy and Nursing Care Facility Business, the Company Jun 2021 Director, the Company Jul 2021 Managing Executive Officer, in charge of Business Strategy, the Company Jun 2023 Director, in charge of Business Strategy, the Company (current)
1961-09-06
Kazushi ONOMATSU
Director
Apr 1988 Joined Hokkaido Bank, Ltd. Mar 2022 Joined the Company Mar 2022 Executive Officer, Deputy General Manager of Operations Division (in charge of Administration), the Company Jun 2023 Director, Deputy General Manager of Operations Division (in charge of Administration), the Company Jul 2023 Director, General Manager of Administration Division, the Company (current)
1963-08-20
Tomohiro MANABE
Director
Dec 1993 Joined Valeo Co., Ltd. (now Hokuyaku Co., Ltd.) Oct 2004 General Manager, Sales Department, Pharmaceutical Sales Division, Valeo Co., Ltd. Oct 2006 Executive Officer and General Manager, Regional Sales Division, Pharmaceutical Sales Division, Valeo Co., Ltd. Jun 2008 Managing Executive Officer, Deputy General Manager of Pharmaceutical Sales Division and General Manager of Regional Sales Division, Valeo Co., Ltd. Jun 2009 Director and Managing Executive Officer, in charge of Pharmaceutical Sales, the Company Jul 2011 Director and Managing Executive Officer, General Manager of Pharmaceutical Sales Division, Hokuyaku Co., Ltd. Jul 2012 Director and Managing Executive Officer, in charge of Pharmaceutical Sales, the Company Jun 2013 Director and Senior Managing Executive Officer, General Manager of Integrated Sales Division and General Manager of Pharmaceutical Sales Division, Hokuyaku Co., Ltd. Jun 2014 Director and Senior Managing Executive Officer, in charge of Pharmaceutical Sales, the Company Jun 2015 Senior Managing Director, in charge of Pharmaceutical Sales, the Company Jun 2018 Senior Managing Executive Officer, in charge of Pharmaceutical Sales, the Company Jul 2018 Senior Managing Executive Officer, in charge of Pharmaceutical Wholesale Business, the Company Jun 2023 Director and Executive Vice President, Integrated Sales Division and General Manager of Pharmaceutical Sales Division, Hokuyaku Co., Ltd. Jun 2023 Senior Executive Officer, in charge of Pharmaceutical Wholesale Business, the Company Jun 2024 Director, in charge of Pharmaceutical Wholesale Business, the Company (current) Oct 2024 Director and Executive Vice President, Hokuyaku Co., Ltd. (current)
1968-12-01
Takuya TSUCHIDA
Director
May 1986 Joined Takeyama Co., Ltd. Jun 2006 Executive Officer, Takeyama Co., Ltd. Jun 2007 Director and Executive Officer, Takeyama Co., Ltd. Jun 2012 Director and Managing Executive Officer, General Manager of Sales Division, Takeyama Co., Ltd. Jun 2012 Executive Officer, the Company Jun 2015 Director and Managing Executive Officer, in charge of Medical Device Sales, the Company Jun 2016 Representative Director, President, Takeyama Co., Ltd. (current) Jun 2016 Senior Managing Director, in charge of Medical Device Sales, the Company Jul 2016 Senior Managing Director, in charge of Medical Device Business, the Company Jun 2018 Senior Managing Executive Officer, in charge of Medical Device Business, the Company Jul 2018 Senior Managing Executive Officer, in charge of Medical Device Wholesale Business, the Company Jun 2023 Senior Executive Officer, in charge of Medical Device Wholesale Business, the Company Jun 2024 Director, in charge of Medical Device Wholesale Business, the Company (current)
1962-10-25
Atsushi MIYAZAKI
Director
Jul 2017 Joined Maple Pharmacy Co., Ltd. Jul 2017 Representative Director, President, Maple Pharmacy Co., Ltd. Jun 2019 Executive Officer, the Company Jul 2019 Executive Officer, in charge of Pharmacy Business and General Manager of Pharmacy Business Division, the Company Jun 2020 Managing Executive Officer, in charge of Pharmacy Business and General Manager of Pharmacy Business Division, the Company Oct 2022 Representative Director, President, Soeru Co., Ltd. (current) Jun 2023 Senior Executive Officer, in charge of Pharmacy Business and General Manager of Pharmacy Business Division, the Company Jun 2024 Director, in charge of Pharmacy Business and General Manager of Pharmacy Business Division, the Company Jul 2024 Director, in charge of Pharmacy Business, the Company (current)
1960-03-28
Yuji SONOKI
Director
Jun 2023 Joined the Company Jun 2023 Advisor, the Company Oct 2023 Executive Officer, the Company Jun 2024 Director, Soeru Co., Ltd. (current) Jun 2024 Director, the Company (current)
1959-02-04
Kiyofumi ISHIMARU
Director
Apr 1980 Joined Computer Services Corporation (now SCSK Corporation) Jan 1998 Joined CSK Hokkaido System Corporation (now SCSK Hokkaido Corporation) Jun 2004 Director, Hokkaido CSK Corporation (now SCSK Hokkaido Corporation) Apr 2007 Managing Executive Officer, Hokkaido CSK Corporation Apr 2012 Representative Director, President, Hokkaido CSK Corporation Apr 2022 Representative Director, Chairman, SCSK Hokkaido Corporation Jun 2023 Director, the Company (current)
1957-08-20
Hiroaki AKAO
Director
Apr 1999 Joined Mazda Motor Corporation May 2004 Joined Seicomart Co., Ltd. (now Seicomart Co., Ltd.) Mar 2006 Director, Seicomart Co., Ltd. Feb 2009 Managing Director, Seicomart Co., Ltd. Feb 2014 Senior Managing Director, Seicomart Co., Ltd. Feb 2016 Representative Director, Executive Vice President, Seicomart Co., Ltd. Apr 2020 Representative Director, President, Seicomart Co., Ltd. (current) Jun 2023 Director, the Company (current)
1976-10-27
Yukinori SAKATA
Director
Mar 1987 Joined Manabe Pharmaceutical Co., Ltd. (now Hokuyaku Co., Ltd.), Sapporo Branch Oct 2002 General Manager, Eniwa Branch, Hokuyaku Co., Ltd. Oct 2003 General Manager, Iwamizawa Branch, Hokuyaku Co., Ltd. Oct 2006 General Manager, Sapporo North Branch, Hokuyaku Co., Ltd. Oct 2009 General Manager, Asahikawa Branch, Hokuyaku Co., Ltd. Jul 2011 General Manager, Kushiro Branch, Hokuyaku Co., Ltd. Oct 2016 Manager, Mulberry Co., Ltd. Jun 2017 Director, Mulberry Co., Ltd. Jun 2021 Managing Director, Mulberry Co., Ltd. Jun 2023 Director and Vice President, Mulberry Co., Ltd. Jun 2025 Senior Executive Officer, the Company Jun 2025 Representative Director, President, Mulberry Co., Ltd. (current) Jun 2025 Director, Morus Co., Ltd. (current) Jul 2025 Senior Executive Officer, in charge of Nursing Care Business, the Company (current)
Toshinori AOYAGI
Full-time Audit & Supervisory Board Member
Mar 1979 Joined Manabe Pharmaceutical Co., Ltd. (now Hokuyaku Co., Ltd.) Apr 1994 General Manager, Sapporo Hounan Branch, Manabe Pharmaceutical Co., Ltd. Apr 1997 General Manager, Sapporo Central Branch, Manabe Pharmaceutical Co., Ltd. Jul 1999 Executive Officer, General Manager of Pharmaceutical Sales Division (in charge of Sapporo area), Manabe Pharmaceutical Co., Ltd. Oct 2009 Director and Executive Officer, Deputy General Manager of Pharmaceutical Sales Division, General Manager of Sales Promotion Department and General Manager of Hospital Sales Department, Manabe Pharmaceutical Co., Ltd. Jun 2015 Director and Managing Executive Officer, Deputy General Manager of Pharmaceutical Sales Division and General Manager of Hospital Sales Department, Manabe Pharmaceutical Co., Ltd. Jul 2018 Director and Managing Executive Officer, Deputy General Manager of Integrated Sales Division, Manabe Pharmaceutical Co., Ltd. Jun 2022 Audit & Supervisory Board Member, the Company (current) Jun 2023 Audit & Supervisory Board Member, Hokuyaku Co., Ltd. (current) Jun 2023 Audit & Supervisory Board Member, Takeyama Co., Ltd. (current)
1956-04-09
Kazunari TSUBONUMA
Audit & Supervisory Board Member
Mar 1985 Registered as Certified Public Accountant Jun 1994 Advisor, Valeo Co., Ltd. (now Hokuyaku Co., Ltd.) Jun 1995 Audit & Supervisory Board Member, Valeo Co., Ltd. Sep 2006 Audit & Supervisory Board Member, the Company (current)
1958-04-03
Masafumi KODERA
Audit & Supervisory Board Member
Apr 1980 Registered as Attorney at Law Jun 2018 Audit & Supervisory Board Member, the Company (current)
1950-05-17
Large Shareholding Reports
Yugen Kaisha Task Planning
2026-09-28
5.42%→5.77%
Annual report (as of 2026-03-31): 6.85%
Itsuwa Kikaku Ltd.
2026-09-28
9.61%→10.71%
Annual report (as of 2026-03-31): 13.03%
Disclosures
No disclosures
Primary Source Filings
EDINET
2026-09-28
Large Shareholding Report
EDINET
2026-09-28
Large Shareholding Report
TDnet
2026-08-07
Q1 Earnings Flash
FY ending Mar 2027
EDINET
2026-06-25
Annual Securities Report
Period: Apr 2025 – Mar 2026
TDnet
2026-06-04
株主総会招集通知
TDnet
2026-02-06
Q3 Earnings Flash
FY ending Mar 2026
EDINET
2025-11-10
Semi-Annual Securities Report
Period: Apr 2025 – Mar 2026
TDnet
2025-08-08
Q1 Earnings Flash
FY ending Mar 2026
EDINET
2025-06-26
Annual Securities Report
Period: Apr 2024 – Mar 2025
TDnet
2025-02-07
Q3 Earnings Flash
FY ending Mar 2025
EDINET
2024-11-08
Semi-Annual Securities Report
Period: Apr 2024 – Mar 2025
TDnet
2024-08-09
Q1 Earnings Flash
FY ending Mar 2025
EDINET
2024-06-28
Annual Securities Report
Period: Apr 2023 – Mar 2024
EDINET
2024-02-14
Quarterly Securities Report
Period: Oct 2023 – Dec 2023
EDINET
2023-11-10
Quarterly Securities Report
Period: Jul 2023 – Sep 2023
EDINET
2023-08-10
Quarterly Securities Report
Period: Apr 2023 – Jun 2023
EDINET
2023-06-29
Annual Securities Report
Period: Apr 2022 – Mar 2023
EDINET
2023-02-10
Quarterly Securities Report
Period: Oct 2022 – Dec 2022
EDINET
2022-11-14
Quarterly Securities Report
EDINET
2022-08-10
Quarterly Securities Report
EDINET
2022-06-30
Annual Securities Report
EDINET
2022-02-10
Quarterly Securities Report
EDINET
2021-11-10
Quarterly Securities Report
EDINET
2021-08-10
Quarterly Securities Report
EDINET
2021-06-30
Annual Securities Report
EDINET
2021-02-10
Quarterly Securities Report
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →